PainReform Ltd. (PRFX): Price and Financial Metrics
GET POWR RATINGS... FREE!
PRFX Stock Price Chart Interactive Chart >
PRFX Price/Volume Stats
|Current price||$2.92||52-week high||$7.84|
|Prev. close||$3.05||52-week low||$2.18|
|Day high||$3.22||Avg. volume||717,900|
|50-day MA||$2.91||Dividend yield||N/A|
|200-day MA||$3.77||Market Cap||30.61M|
PainReform Ltd. (PRFX) Company Bio
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Most Popular Stories View All
PRFX Latest News Stream
|Loading, please wait...|
PRFX Latest Social Stream
View Full PRFX Social Stream
Latest PRFX News From Around the Web
Below are the latest news stories about Painreform Ltd that investors may wish to consider to help them evaluate PRFX as an investment opportunity.
Good morning, trader!
Shifting manufacturing and scale up operation to U.S.-based Contract Development and Manufacturing Organization for PRF-110TEL AVIV, Israel, Aug. 16, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the second quarter ended June 30, 2021. "We are continuing the steady progress towards commencement of our Phase 3 c
Bitcoin (BTC) mining stocks are all soaring today as investors are excited about a BTC conference trending on Twitter today.
Trxade Health (MEDS) stock is experiencing massive movement today as investors react to news of a deal from the telemedicine company.
PRFX Price Returns